WORCESTER — Two Worcester County companies were among 38 life sciences firms statewide sharing nearly $40 million in tax incentives Gov. Maura Healey announced Tuesday, Sept. 22, a round expected to create 1,644 jobs across Massachusetts.
- Eyepoint Inc., which is expanding in Northbridge, received $1,000,000 tied to a commitment of 40 new jobs.
- Rentschler Biopharma Inc., expanding in Milford, received $517,500 for 23 jobs.
Healey announced the full round of awards at SMC Ltd.’s facility in Devens, alongside Economic Development Secretary Eric Paley and Massachusetts Life Sciences Center Interim CEO Liz Graham. The awards were made through the center’s Tax Incentive Program, which supports companies expanding research, development and manufacturing operations in the state. Of the 38 companies receiving awards, 31 are expanding outside Boston and Cambridge and account for 71% of the new jobs expected from this round, according to the state.
“Massachusetts leads the world in life sciences because we invest in the people and companies that are creating the jobs, treatments and technologies of the future,” Healey said in a statement.
Since the Massachusetts Life Sciences Center was established, companies participating in the tax incentive program have committed to creating more than 22,300 jobs, according to the state. In November 2024, Healey signed the Mass Leads Act, which raised the statutory cap on the program from $30 million to $40 million and made other changes intended to strengthen it.
Recipients are required to maintain their job commitments over a three-year period and must file regular reports documenting jobs created. The program is jointly administered by the Massachusetts Life Sciences Center and the Massachusetts Department of Revenue, which handles its technical administration.
The remaining 36 companies receiving awards in this round, all outside Worcester County, are listed below.
| Company | Location | Incentive | Jobs |
|---|---|---|---|
| Alloy Therapeutics Inc. | Waltham | $180,000 | 10 |
| Ardelyx Inc. | Waltham | $277,500 | 15 |
| AstraZeneca Pharmaceuticals LP | Cambridge | $900,000 | 50 |
| Bristol-Myers Squibb Company | Devens | $2,875,000 | 125 |
| CBSET Inc. | Lexington | $660,000 | 33 |
| Cogent Biosciences Inc. | Waltham | $360,000 | 20 |
| Dash Bio Inc. | Waltham | $285,000 | 12 |
| Dyne Therapeutics Inc. | Waltham | $937,500 | 50 |
| Gentuity LLC | Sudbury | $276,000 | 15 |
| Insulet Corporation | Acton | $10,000,000 | 250 |
| IPG Medical Corporation | Marlborough | $195,000 | 10 |
| Kailera Therapeutics Inc. | Waltham | $900,000 | 50 |
| KalVista Pharmaceuticals Inc. | Framingham | $324,000 | 18 |
| Kymera Therapeutics Inc. | Watertown | $630,000 | 35 |
| Lexington Medical Inc. | Bedford | $180,000 | 10 |
| Lila Sciences Inc. | Cambridge | $3,600,000 | 200 |
| Madrigal Pharmaceuticals Inc. | Waltham | $900,000 | 50 |
| Mercy BioAnalytics Inc. | Waltham | $120,000 | 5 |
| Monte Rosa Therapeutics Inc. | Boston | $720,000 | 40 |
| Nanopath Inc. | Cambridge | $288,000 | 12 |
| Olaris Inc. | Framingham | $125,000 | 5 |
| Pramand LLC | Burlington | $257,500 | 10 |
| Rapport Therapeutics Inc. | Boston | $483,000 | 21 |
| Repligen Corporation | Marlborough | $415,000 | 20 |
| Rhythm Pharmaceuticals Inc. | Boston | $462,500 | 25 |
| Sanegene Bio USA Inc. | Woburn | $235,000 | 10 |
| SMC Ltd. | Devens | $1,350,000 | 54 |
| Spear Bio Inc. | Woburn | $235,000 | 10 |
| Terrestrial Bio Inc. | Woburn | $1,080,000 | 36 |
| TransMedics Group Inc. | Andover | $1,860,000 | 62 |
| Triveni Bio Inc. | Watertown | $288,000 | 12 |
| Verastem Inc. | Needham | $437,000 | 19 |
| Vericel Corporation | Burlington | $1,100,000 | 50 |
| Vertex Pharmaceuticals Inc. | Boston | $3,025,000 | 121 |
| Werfen | Bedford | $1,303,500 | 66 |
| Zoll Medical Corporation | Chelmsford | $1,100,000 | 50 |
